oasis semaglutide First oral made a strong impression in OASIS-1 #obesity with 15% #weightloss now orforglipron leads the impressive pack of new small molecule oral GLP-1RA with robust #Weightloss and good tolerability ADA2023 In the OASIS 4 phase
Description
GLP-1s may influence the pathways that promote cancer not only by controlling weight and blood sugar but also through their anti-inflammatory effects independent of these traditional risk factors
If you are ready to take the next step towards a healthier, more vibrant you, we invite you to explore our offerings
Eli Lilly, the manufacturer of the injectable weight-loss medication Zepbound, has its own oral GLP-1 drug in the pipeline, orforglipron, which is being investigated as a treatment for both type 2 diabetes and obesity
Why this matters for you: The availability of compounded GLP-1s is tied to a regulatory and supply reality that can change
The keto diet is similar to starvation in that both glucose and insulin plasma levels are low
No matter where you are in your weight loss journey, you may benefit from these medications
